Despite Republican attacks, the budget blueprint passed by the GOP-controlled House of Representatives likely would require an individual mandate for Medicare.
NATIONAL REPORTS-Despite relentless Republican attacks on the health reform law's individual mandate, the budget blueprint passed by the GOP-controlled House of Representatives likely would require a similar individual mandate for Medicare, experts say.
Without a mandate, they warn, the Republicans' Medicare overhaul would leave many seniors uninsured because its proposed voucher payments would be too puny to buy good coverage. And without tough insurance market rules like those in last year's reform law, health plans would cherrypick younger and healthier subscribers, critics say.
To make the GOP proposal work, there are three possibilities.
Conservative analysts counter that rising Medicare costs will force beneficiaries to bear higher costs even under traditional Medicare, and turning Medicare into a fully market-based system will give beneficiaries more choice and control costs more effectively.
"There's a genius in the marketplace, and we haven't utilized that," says Grace-Marie Turner, president of the Galen Institute in Alexandria, Va.
Moon, however, says there's no evidence that competition among private health plans controls costs better than traditional Medicare.
MEDICARE VOUCHERS
The House bill, introduced by Budget Committee Chairman Paul Ryan (R-Wis.) would convert Medicare from a defined-benefit to a defined-contribution program for all new beneficiaries starting in 2022, and gradually raise the eligibility age to 67 by 2033. While the budget bill lacks details, seniors would pick a private plan through a new Medicare insurance exchange, and the government would pay the insurer the defined amount, adjusted for the person's age and health status.
The Ryan plan also would change Medicaid to a state block-grant program in 2013. In addition, it would give dual eligibles a flat annual sum for a medical savings account-starting at $7,800 and rising with the consumer price index. Further, it would repeal most of the Patient Protection and Affordable Care Act-including the Medicaid expansion, insurance subsidies and alternative payment pilots-though it would retain the Medicare spending caps.
The nonpartisan Congressional Budget Office (CBO) projects that the House bill would drive down overall federal healthcare spending from 12% of GDP in 2050 to 5%. The bill's main Medicare cost-cutting mechanism is tying the annual increase in the voucher amount to the urban consumer price index, which historically has risen much slower than medical costs.
But Ryan's Medicare plan has run into heavy opposition because the CBO also says the plan would impose sharply higher costs on beneficiaries. While the voucher amount would start at an average of $8,000 per beneficiary-the same amount traditional Medicare would pay-the CBO projected that by 2030 typical 65-year-olds would shoulder 68% of their own healthcare costs, compared with 25% to 30% under the current model. Seniors in the top 8% of the income distribution would have to pay even more, and many would choose not to purchase insurance.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More